Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Zhong WZ" with an ORCID

Wen-zhao Zhong
No affiliation detected
4
Publications
1,929
Citations
View profile

Search results

1-25 of 246 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma.
Li HJ, Qiu ZB, Wang MM, Zhang C, Hong HZ, Fu R, Peng LS, Huang C, Cui Q, Zhang JT, Ren JY, Jiang L, Wu YL, Zhong WZ
J Thorac Oncol, S1556-0864(24)02330-X, 19 Sep 2024
Cited by: 0 articles | PMID: 39306192
Add to export list
Metabolically activated energetic materials mediate cellular anabolism for bone regeneration.
Li J, Zhang X, Peng ZX, Chen JH, Liang JH, Ke LQ, Huang D, Cheng WX, Lin S, Li G, Hou R, Zhong WZ, Lin ZJ, Qin L, Chen GQ, Zhang P
Trends Biotechnol, S0167-7799(24)00213-0, 04 Sep 2024
Cited by: 0 articles | PMID: 39237385
Add to export list
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC.
Li YS, Lai WP, Yin K, Zheng MM, Tu HY, Guo WB, Li L, Lin SH, Wang Z, Zeng L, Jiang BY, Chen ZH, Zhou Q, Zhang XC, Yang JJ, Zhong WZ, Yang XN, Wang BC, Pan Y, [...] Wu YL
Cell Rep, 43(8):114613, 07 Aug 2024
Cited by: 0 articles | PMID: 39116206
Add to export list
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Dong S, Wang Z, Zhang JT, Yan B, Zhang C, Gao X, Sun H, Li YS, Yan HH, Tu HY, Liu SM, Gong Y, Gao W, Huang J, Liao RQ, Lin JT, Ke EE, Xu Z, Zhang X, [...] Wu YL
JAMA Oncol, 10(7):932-940, 01 Jul 2024
Cited by: 2 articles | PMID: 38869865
Add to export list
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
Zhang C, Sun YX, Yi DC, Jiang BY, Yan LX, Liu ZD, Peng LS, Zhang WJ, Sun H, Chen ZY, Wang DH, Peng D, Chen SA, Li SQ, Zhang Z, Tan XY, Yang J, Zhao ZY, Zhang WT, [...] Zhong WZ
Cell Rep Med, 5(7):101615, 18 Jun 2024
Cited by: 1 article | PMID: 38897205 | PMCID: PMC11293361
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Redox^high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma.
Wei XW, Lu C, Zhang YC, Fan X, Xu CR, Chen ZH, Wang F, Yang XR, Deng JY, Yang MY, Gou Q, Mei SQ, Luo WC, Zhong RW, Zhong WZ, Yang JJ, Zhang XC, Tu HY, Wu YL, Zhou Q
Oncoimmunology, 13(1):2340154, 09 Apr 2024
Cited by: 0 articles | PMID: 38601319 | PMCID: PMC11005803
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CtDNA based molecular residual disease outcompetes carcinoembryonic antigen in predicting postoperative recurrence of non-small cell lung cancer.
Li HJ, Zhang JT, Dong S, Yang XN, Cui SR, Wu YL, Zhong WZ
J Thorac Dis, 16(1):423-429, 29 Jan 2024
Cited by: 0 articles | PMID: 38410594 | PMCID: PMC10894388
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of preoperative [¹⁸F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
Lin JT, Li XM, Zhong WZ, Hou QY, Liu CL, Yu XY, Ye KY, Cheng YL, Du JY, Sun YQ, Zhang FG, Yan HH, Liao RQ, Dong S, Jiang BY, Liu SY, Wu YL, Yang XN
Ann Nucl Med, 38(3):188-198, 25 Dec 2023
Cited by: 3 articles | PMID: 38145431
Add to export list
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis.
Wang J, Wu YL, Lu S, Wang Q, Li S, Zhong WZ, Wang Q, Li W, Wang B, Chen J, Cheng Y, Duan H, Li G, Shan L, Liu Y, Liu J, Huang X, Bolanos A, He J
JTO Clin Res Rep, 5(2):100621, 17 Dec 2023
Cited by: 3 articles | PMID: 38371194 | PMCID: PMC10874739
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Maggie Liu SY, Huang J, Deng JY, Xu CR, Yan HH, Yang MY, Li YS, Ke EE, Zheng MY, Wang Z, Lin JX, Gan B, Zhang XC, Chen HJ, Wang BC, Tu HY, Yang JJ, Zhong WZ, Li Y, [...] Wu YL
Sci Bull (Beijing), 69(4):535-543, 26 Dec 2023
Cited by: 3 articles | PMID: 38185589
Add to export list
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.
Wang MM, Li JQ, Dou SH, Li HJ, Qiu ZB, Zhang C, Yang XW, Zhang JT, Qiu XH, Xie HS, Tang WF, Cheng ML, Yan HH, Yang XN, Wu YL, Zhang XG, Yang L, Zhong WZ
Eur J Cardiothorac Surg, 64(6):ezad373, 01 Dec 2023
Cited by: 0 articles | PMID: 37975876 | PMCID: PMC10753921
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.
Liu SY, Dong S, Yang XN, Liao RQ, Jiang BY, Wang Q, Ben XS, Qiao GB, Lin JT, Yan HH, Yan LX, Nie Q, Tu HY, Wang BC, Yang JJ, Zhou Q, Li HR, Liu K, Wu W, [...] Wu YL
Signal Transduct Target Ther, 8(1):442, 06 Dec 2023
Cited by: 6 articles | PMID: 38057314 | PMCID: PMC10700550
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.
Lu C, Wei XW, Wang Z, Zhou Z, Liu YT, Zheng D, He Y, Xie ZH, Li Y, Zhang Y, Zhang YC, Huang ZJ, Mei SQ, Liu JQ, Guan XH, Deng Y, Chen ZH, Tu HY, Xu CR, [...] Zhou Q
J Thorac Oncol, 19(4):601-612, 20 Nov 2023
Cited by: 1 article | PMID: 37981218
Add to export list
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).
Zhang JT, Dong S, Gu WQ, Zhao N, Liang Y, Tang WF, Liu SY, Wang F, Wang GS, Peng B, Wu N, Yan S, Geng GJ, Xie ZF, Yang YL, Zhang JH, Zhang T, Yang N, Jiao WJ, [...] Wu YL
Clin Lung Cancer, 25(1):e1-e4, 06 Oct 2023
Cited by: 2 articles | PMID: 37880076
Add to export list
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial.
Maggie Liu SY, Dong XR, Wang Z, Du Y, Cui JW, Chu Q, Xu BF, Zheng MY, Deng JY, Lu C, Wei XW, Li YS, Zheng MM, Yang MY, Huang J, Li A, Bai XY, Sun YL, Xu CR, [...] Wu YL
EClinicalMedicine, 64:102238, 22 Sep 2023
Cited by: 4 articles | PMID: 37781161 | PMCID: PMC10541475
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.
Pan Y, Zhang JT, Gao X, Chen ZY, Yan B, Tan PX, Yang XR, Gao W, Gong Y, Tian Z, Liu SM, Lin H, Sun H, Huang J, Liu SY, Yan HH, Dong S, Xu CR, Chen HJ, [...] Wu YL
Cancer Cell, 41(10):1763-1773.e4, 01 Oct 2023
Cited by: 9 articles | PMID: 37816331
Add to export list
A novel image deep learning-based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign.
Yang X, Chu XP, Huang S, Xiao Y, Li D, Su X, Qi YF, Qiu ZB, Wang Y, Wang Y, Tang WF, Wu YL, Zhu Q, Liang H, Zhong WZ
Eur Radiol, 34(3):2048-2061, 02 Sep 2023
Cited by: 0 articles | PMID: 37658883
Add to export list
Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
Yang X, Xiao Y, Hu H, Qiu ZB, Qi YF, Wang MM, Wu YL, Zhong WZ
Ann Surg Oncol, 30(12):7400-7411, 01 Sep 2023
Cited by: 1 article | PMID: 37658270
Add to export list
Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer.
Zhang SL, Zhang CY, Chen YQ, Li YF, Xie Z, Zhang XC, Zhou Q, Zhong WZ, Huang J, Sun H, Zheng MY, Xiao FM, Yan HH, Lu DX, Lv ZY, Wu YL, Chen HJ, Yang JJ
J Thorac Dis, 15(9):4620-4635, 04 Sep 2023
Cited by: 1 article | PMID: 37868836 | PMCID: PMC10586967
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma.
Zhang JT, Zhang J, Wang SR, Yan LX, Qin J, Yin K, Chu XP, Wang MM, Hong HZ, Lv ZY, Dong S, Jiang BY, Zhang XC, Liu X, Zhou Q, Wu YL, Zhong WZ
iScience, 26(10):107699, 21 Aug 2023
Cited by: 3 articles | PMID: 37810252 | PMCID: PMC10550719
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung Adenocarcinoma.
Yang X, Zhong WZ
Ann Surg Oncol, 30(12):7499-7500, 15 Aug 2023
Cited by: 0 articles | PMID: 37581852
Add to export list
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
Deng JY, Gou Q, Yang L, Chen ZH, Yang MY, Yang XR, Yan HH, Wei XW, Liu JQ, Su J, Zhong WZ, Xu CR, Wu YL, Zhou Q
J Immunother Cancer, 11(7):e007218, 01 Jul 2023
Cited by: 5 articles | PMID: 37463790 | PMCID: PMC10357800
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer.
Tang WF, Fan XJ, Bao H, Fu R, Liang Y, Wu M, Zhang C, Zhang C, Su J, Wu YL, Zhong WZ
Oncoimmunology, 12(1):2215112, 27 May 2023
Cited by: 1 article | PMID: 37261085 | PMCID: PMC10228401
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma.
Hong HZ, Li JK, Zhang JT, Li HJ, Peng LS, Wu YL, Zhong WZ
Lung Cancer, 181:107220, 29 Apr 2023
Cited by: 0 articles | PMID: 37263181
Add to export list
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.
Tu HY, Yin K, Zhao X, Ke EE, Wu SP, Li YS, Zheng MM, Liu SM, Xu CR, Sun YL, Lin JX, Bai XY, Zhang YC, Zhou Q, Yang JJ, Zhong WZ, Wang BC, Zhang XC, Zhu D, [...] Wu YL
Mol Oncol, 17(8):1581-1594, 29 Apr 2023
Cited by: 0 articles | PMID: 37078460 | PMCID: PMC10399722
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 246 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Zhong WZ" with an ORCID

Search results

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma.

Metabolically activated energetic materials mediate cellular anabolism for bone regeneration.

Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC.

Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

Redox^high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma.

CtDNA based molecular residual disease outcompetes carcinoembryonic antigen in predicting postoperative recurrence of non-small cell lung cancer.

Impact of preoperative [¹⁸F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.

Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis.

PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.

Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.

Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.

Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial.

Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.

A novel image deep learning-based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign.

Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer.

Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma.

ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung Adenocarcinoma.

Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.

Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer.

Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma.

Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.

Partnerships & funding

Search life-sciences literature (45,104,145 articles, preprints and more)

Suggested authors matching "AUTH:Zhong WZ" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Zhong WZ" with an ORCID